Zacks Research Cuts Earnings Estimates for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Zacks Research cut their Q4 2024 earnings per share estimates for DENTSPLY SIRONA in a research note issued to investors on Thursday, November 28th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will post earnings per share of $0.45 for the quarter, down from their prior forecast of $0.58. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.42 EPS, Q2 2025 earnings at $0.51 EPS, Q3 2025 earnings at $0.50 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $1.97 EPS, Q1 2026 earnings at $0.48 EPS, Q2 2026 earnings at $0.55 EPS and Q3 2026 earnings at $0.53 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the previous year, the firm earned $0.49 EPS. The company’s quarterly revenue was up .4% compared to the same quarter last year.

Several other brokerages also recently weighed in on XRAY. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday. Leerink Partners downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Finally, Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $29.22.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $19.39 on Monday. The firm’s fifty day simple moving average is $22.29 and its two-hundred day simple moving average is $24.62. The firm has a market capitalization of $3.85 billion, a P/E ratio of -9.37, a P/E/G ratio of 1.94 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $37.60.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. Synovus Financial Corp purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at about $240,000. Tidal Investments LLC acquired a new position in DENTSPLY SIRONA in the third quarter valued at approximately $602,000. Wilmington Savings Fund Society FSB purchased a new stake in DENTSPLY SIRONA in the 3rd quarter worth approximately $261,000. M&T Bank Corp grew its position in DENTSPLY SIRONA by 5.6% during the third quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier’s stock valued at $1,058,000 after buying an additional 2,062 shares during the period. Finally, Barclays PLC grew its position in shares of DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after acquiring an additional 54,920 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.